The impact of reporting estimated glomerular filtration rate

Renal Failure

Volumn 33, Issue 5, 2011, Pages 486-488

  Geara, Abdallah Sassine ^a   Azzi, Nadine ^b   Ghimire, Pratima ^b   Abdallah, Marie ^b   Siddiqui, Ayesha ^b   Bassil, Claude ^b   El Sayegh, Suzanne ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

Chronic kidney disease; glomerular filtration rate; MDRD; nephrotoxicity

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CONTRAST MEDIUM; CREATININE; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL;

AGED; ANTI-BACTERIAL AGENTS; CONTRAST MEDIA; CREATININE; DRUG TOXICITY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; RENAL INSUFFICIENCY, CHRONIC;

EID: 79956276706     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.574768     Document Type: Article

References (12)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc. 2007; 298(17):2038-2047. (Pubitemid 350074801)
2. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139(2): 137-147.
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl. 1):S1-S266.
4. Accetta NA, Gladstone EH, DiSogra C, Wright EC, Briggs M, Narva AS. Prevalence of estimated GFR reporting among US clinical laboratories. Am J Kidney Dis. 2008;52(4):778-787.
5. Jain AK, McLeod I, Huo C, et al. When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int. 2009;76(3): 318-323.
6. Hemmelgarn BR, Zhang J, Manns BJ, et al. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. J Am Med Assoc. 2010;303(12): 1151-1158.
7. Gentile G, Postorino M, Mooring RD, et al. Estimated GFR reporting is not sufficient to allow detection of chronic kidney disease in an Italian regional hospital. BMC Nephrol. 2009;10:24.
8. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137(6):479-486. (Pubitemid 35024618)
9. Richards N, Harris K, Whitfield M, et al. The impact of population-based identification of chronic kidney disease using estimated glomerular filtration rate (eGFR) reporting. Nephrol Dial Transplant. 2008;23(2):556-561. (Pubitemid 351767654)
10. Richards N, Harris K, Whitfield M, et al. Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant. 2008;23(2):549-555. (Pubitemid 351767656)
11. Glassock RJ, Winearls C. Screening for CKD with eGFR: Doubts and dangers. Clin J Am Soc Nephrol. 2008;3(5):1563-1568.
12. den Hartog JR, Reese PP, Cizman B, Feldman HI. The costs and benefits of automatic estimated glomerular filtration rate reporting. Clin J Am Soc Nephrol. 2009;4(2):419-427.